{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:01:36Z","timestamp":1761166896222,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jocd.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T09:00:23Z","timestamp":1496394023000},"page":"513-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Time of Administration of Teriparatide on Bone Mineral Density in Glucocorticoid-Induced Osteoporosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Silvina R.","family":"Mastaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocd.2017.05.005_bib0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.05.005_bib0015","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"428","article-title":"Parathyroid hormone treatment for osteoporosis","author":"Cosman","year":"2013"},{"issue":"5","key":"10.1016\/j.jocd.2017.05.005_bib0020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s001980070111","article-title":"Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis","volume":"11","author":"Lane","year":"2000","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jocd.2017.05.005_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3899\/jrheum.090411","article-title":"Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis","volume":"37","author":"Devogelaer","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jocd.2017.05.005_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2017.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1359\/jbmr.080506","article-title":"Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment","volume":"23","author":"Obermayer-Pietsch","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.jocd.2017.05.005_bib0040","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00198-012-1955-4","article-title":"Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis","volume":"23","author":"Michalska","year":"2012","journal-title":"Ostporosis Int"},{"issue":"5","key":"10.1016\/j.jocd.2017.05.005_bib0045","first-page":"11","article-title":"Circadian rhythm of urinary total and free hydroxyproline excretion and its relation to creatinine excretion","volume":"75","author":"Mautalen","year":"1970","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jocd.2017.05.005_bib0050","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S8756-3282(02)00742-1","article-title":"Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis","volume":"30","author":"Sasaki","year":"2002","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.jocd.2017.05.005_bib0055","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1210\/jc.2006-1832","article-title":"The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion","volume":"92","author":"Joseph","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695017300628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695017300628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:40:40Z","timestamp":1761082840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695017300628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1094695017300628"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2017.05.005","relation":{},"ISSN":["1094-6950"],"issn-type":[{"type":"print","value":"1094-6950"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Time of Administration of Teriparatide on Bone Mineral Density in Glucocorticoid-Induced Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The International Society for Clinical Densitometry.","name":"copyright","label":"Copyright"}]}}